Because our focus was on the initiation of insulin resistance and hyperinsulinemia in subjects with increased fatness but normal blood glucose, we excluded participants who were diabetic patients or lean participants who had fasting serum insulin levels above 30 mU/l; and participants who used beta-blockers, insulin, or statins. The gene discussed is INS; the disease is Hyperinsulinemia.